Having trouble accessing articles? Reset your cache.

Evidation, Lilly and Apple show digital tech could identify, monitor Alzheimer’s

Data from a study by Evidation, Eli Lilly and Apple suggest digital biomarkers collected via mobile devices could be used to identify patients at risk for mild

Read the full 279 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE